Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
small molecules
Biotech
Praxis plots path to FDA after phase 3 wins in essential tremor
The trials demonstrated the benefits of ulixacaltamide in essential tremor after a previously grim outlook from one study earlier this year.
Zoey Becker
Oct 16, 2025 11:48am
Lilly pads oral GLP-1 case with pair of phase 3 diabetes wins
Oct 15, 2025 9:48am
Merck inks $349M biobucks deal to apply AI to tricky targets
Sep 23, 2025 7:00am
Lilly links up with Gate in $856M biobucks deal
Jul 24, 2025 2:32pm
Novo Nordisk inks $812M Deep Apple deal to pursue obesity target
Jun 11, 2025 7:00am
Novo inks $2.2B deal for Septerna's preclinical obesity programs
May 14, 2025 7:00am